CPMV
Mosaic ImmunoEngineering, Inc.
0.4000
+0.0000+0%
Dec 16, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
2.90M
P/E (TTM)
-
Basic EPS (TTM)
-0.09
Dividend Yield
0%

Recent Filings

About 

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

CEO
Mr. Steven W. King
IPO
1/2/2013
Website
https://www.mosaicie.com
Employees
2
Sector
Healthcare
Industry
Biotechnology

Related Companies  

CBIO
Crescent Biopharma, Inc.
12.92-0.29
CERO
CERo Therapeutics Holdings, Inc
0.09-0.01
CMMB
Chemomab Therapeutics Ltd.
2.06+0.00
ENVB
Enveric Biosciences, Inc.
5.24-0.12
FBLG
FibroBiologics, Inc.
0.24-0.02
IMA
ImageneBio, Inc.
6.25+0.08
IMVT
Immunovant, Inc.
26.61+0.61
MURA
Mural Oncology plc
2.04+2.04
NWBO
Northwest Biotherapeutics, Inc.
0.25+0.01
PTIX
Protagenic Therapeutics, Inc.
1.52-0.07